Cargando…

False Positive B-Cells Crossmatch after Prior Rituximab Exposure of the Kidney Donor

Crossmatching is essential prior to kidney transplantation to confirm compatibility between the donor and the recipient, particularly to prevent acute antibody-mediated rejection. An unexpected positive crossmatch may be obtained in recipients with an autoimmune disease or preexisting antibodies not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desoutter, Judith, Apithy, Marie-Joëlle, Bartczak, Ségolène, Guillaume, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864553/ https://www.ncbi.nlm.nih.gov/pubmed/27239362 http://dx.doi.org/10.1155/2016/4534898

Ejemplares similares

Solutions to Avoid False Positives for Rituximab in Pre-Transplant Crossmatches
por: Colmenero Velazquez, Argentina, et al.
Publicado: (2020)

BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation
por: Peacock, S., et al.
Publicado: (2021)

Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation
por: Peng, Bo, et al.
Publicado: (2019)

Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft
por: Aoki, Taku, et al.
Publicado: (2012)

Implication of a positive virtual crossmatch with negative flow crossmatch: A mind-boggler
por: Chowdhry, Mohit, et al.
Publicado: (2020)

Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody Titer
por: Mohamadou, Inna, et al.
Publicado: (2023)

Principles of Virtual Crossmatch Testing for Kidney Transplantation
por: Bhaskaran, Madhu C., et al.
Publicado: (2022)

Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization
por: Osickova, Klara, et al.
Publicado: (2021)

Impact of Low-level Donor-specific Antibody Determined With a Positive Luminex and Negative Flow Cytometric Crossmatch on Kidney Transplantation Outcomes
por: Nam, Minjeong, et al.
Publicado: (2023)

The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation
por: Kim, Young-Kyu, et al.
Publicado: (2013)

Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome
por: Meneghini, Maria, et al.
Publicado: (2018)

CASE REPORT: Serial Cases of False-Positive Flow-Cytometry T Cell Crossmatch Associated With Anti–Blood Type Antibodies in Patients Undergoing ABO-Incompatible Kidney Transplantation
por: Hayashi, Ayaka, et al.
Publicado: (2022)

Accuracy of point‐of‐care crossmatching methods and crossmatch incompatibility in critically ill dogs
por: Marshall, Hayden, et al.
Publicado: (2020)

Artificially Positive Crossmatches Not Leading to the Refusal of Kidney Donations due to the Usage of Adequate Diagnostic Tools
por: Schlaf, G., et al.
Publicado: (2013)

Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines
por: Couzi, Lionel, et al.
Publicado: (2023)

Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report
por: Song, Seung Hwan, et al.
Publicado: (2016)

Immediate transfusion without crossmatching
por: Moriwaki, Y, et al.
Publicado: (2008)

Successful kidney transplantation with a well-matched donor despite a positive crossmatch; detection and management of sensitization secondary to an alternate allelic variant of ‘self’ HLA
por: Clark, Brendan, et al.
Publicado: (2011)

Modified stall‐side crossmatch for transfusions in horses
por: Casenave, Pauline, et al.
Publicado: (2019)

Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience
por: Kang, Hyunhye, et al.
Publicado: (2021)

Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch
por: Yamamoto, Takayuki, et al.
Publicado: (2022)

Improving Crossmatch Techniques and Graft Outcomes
por: Vincent, L.
Publicado: (2018)

C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch
por: Arreola-Guerra, José M., et al.
Publicado: (2016)

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
por: Jordan, Stanley C., et al.
Publicado: (2021)

ELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors' Cell Lysates
por: Schlaf, G., et al.
Publicado: (2015)

Therapeutic Plasma Exchange Ameliorates Incompatible Crossmatches
por: Özen, Mehmet, et al.
Publicado: (2016)

Practical Solutions for Problems in Blood Grouping and Crossmatching
por: Andıç, Neslihan
Publicado: (2022)

Crossmatch: Alloimmunization versus unspecific agglutination reactions?
por: Giger, Urs
Publicado: (2023)

Correlation of Pretransplant Donor-specific Antibody Assay Using Luminex Crossmatch with Graft Outcome in Renal Transplant Patients
por: Vimal, M., et al.
Publicado: (2017)

Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation
por: Ku, Terrance J.Y., et al.
Publicado: (2020)

The Assessment and Outcomes of Crossmatching in Lung Transplantation in Korean Patients
por: Kim, Ha Eun, et al.
Publicado: (2022)

Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges
por: Locke, Arlene F., et al.
Publicado: (2023)

Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
por: Song, Eun Young, et al.
Publicado: (2012)

Liver Transplantation in Recipients With a Positive Crossmatch: A Retrospective Single-Center Match-Pair Analysis
por: Krendl, Felix J., et al.
Publicado: (2023)

MICA and NKG2D variants as risk factors in spondyloarthritis: a case–control study
por: Fechtenbaum, Marie, et al.
Publicado: (2018)

Human leukocyte antigen typing and crossmatch: A comprehensive review
por: Althaf, Mohammed Mahdi, et al.
Publicado: (2017)

Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation
por: Baranwal, Ajay Kumar, et al.
Publicado: (2017)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Endourological Management of Urolithiasis in Donor Kidneys prior to Renal Transplant
por: Vasdev, Nikhil, et al.
Publicado: (2011)

Meneghini M, Melilli E, Martorell J, et al. Combining sensitive crossmatch assays with donor/recipient human leukocyte antigen eplet matching predicts living-donor kidney transplant outcome. Kidney Int Rep. 2018;3:926–938
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ihah1qmkab6su9d7bvbo0hbqp9